Karen A. Heichman, PhD
Vice President, Oncology Technology Development and In-licensing
Dr. Karen Heichman is the vice president of technology development and in-licensing in the area of oncology at ARUP and an adjunct associate professor at the University of Utah School of Medicine. Her role at ARUP involves both developing and managing scientific and business collaborations, with the goal of identifying and implementing new oncology tests and technologies for use in the clinical laboratory setting. She is also involved in developing and managing programs partnerships with the pharmaceutical industry. Dr. Heichman holds an AB in genetics from the University of California at Berkeley and a PhD in biological chemistry from the UCLA School of Medicine. She trained as a postdoctoral fellow in the field of cycle control at the Fred Hutchinson Cancer Research Center in Seattle. Dr. Heichman has more than 25 years of scientific experience in both corporate and academic institutions. Prior to joining ARUP, she spent several years at Myriad Genetics where she was the vice president of proteomic research and three years at the Huntsman Cancer Institute at the University of Utah as the director of cancer systems biology and resources. She has been a longstanding member of the National Cancer Institute Cancer Center's Clinical Cancer Investigations Committee, where she is involved in clinical trial design and evaluation.